[Oral administration of a chymotrypsin-labile synthetic peptide, a new test for exocrine pancreatic function, and its diagnostic value in pancreatic diseases (author's transl)].
D010129:4-Aminobenzoic Acid / Q000652:urine; D000284:Administration, Oral; D062365:Aminobenzoates; D002918:Chymotrypsin / Q000494:pharmacology; D006801:Humans; D010182:Pancreatic Diseases / Q000175:diagnosis*; D010186:Pancreatic Function Tests / Q000379:methods*; D014443:Tyrosine / Q000031:analogs & derivatives; D062366:para-Aminobenzoates
D062365:Aminobenzoates; D062366:para-Aminobenzoates; C006717:bentiromide; D014443:Tyrosine; D002918:Chymotrypsin; D010129:4-Aminobenzoic Acid